Skip to main content

Advertisement

Table 1 Demographic statistics of study participants

From: Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

  Discovery dataset (N = 8,844) Validation datasetb (N = 3,606)
  Case Control Case Control
Stratuma (N = 2,124) (N = 6,720) (N = 1,618) (N = 1,988)
IMSGC UK, Affy 500K 17.5% 40.9% - -
IMSGC US, Affy 500K 13.2% 23.3% - -
BWH, Affy 6.0 32.2% 23.9% - -
Gene MSA CH, Illumina 550K 9.6% 2.9% - -
Gene MSA NL, Illumina 550K 8.9% 3.1% - -
Gene MSA US, Illumina 550K 18.6% 5.9% - -
Male 27.9% 50.3% 27.5% 38.1%
Female 72.1% 49.7% 72.5% 61.9%
DRB1*15:01 + 52.7% 25.1% 56.9% 29.8%
DRB1*15:01 - 47.3% 74.9% 43.1% 70.2%
  1. aDatasets described in [24]. In each pair of matched cases and controls, all subjects are genotyped using the same genome-wide platform. bDatasets described in [12], with 1,618 Australian and New Zealand cases (Illumina Hap370CNV) matched with 1,988 US controls (Illumina Infinium).